Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2025
Title: Yongchao Yao: Innovator in Antibody Library Construction and Chimeric Antigen Receptors
Introduction
Yongchao Yao is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of biomedical technology, particularly in the development of innovative methods for antibody library construction and chimeric antigen receptors. With a total of 2 patents, his work is paving the way for advancements in targeted therapies.
Latest Patents
Yao's latest patents include a method for constructing an antibody library and its applications. This method involves inserting a first element and a second element into the same vector or different vectors, followed by transfecting these vectors into cells to create an antibody expression cell library. The first element consists of CIS activators and selection marker genes, while the second element includes the extracellular antibody library coding domain, Notch nuclear structure domain, and intracellular transcription structure domain.
Another notable patent is for a chimeric antigen receptor that can identify the malarial protein VAR2CSA. This receptor is designed to target various tumor cells by binding to placental-like chondroitin sulfate A on the surface of these cells. This innovative approach has the potential to enhance the effectiveness of cancer therapies.
Career Highlights
Yongchao Yao has worked with several companies in the biomedical field, including Cas Lamvac Biomedical Technology Co., Ltd. and Shenzhen Istirbio Co., Ltd. His experience in these organizations has contributed to his expertise in developing cutting-edge technologies.
Collaborations
Yao has collaborated with notable colleagues such as Wen Hu and Wenzhong Guo. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Yongchao Yao's contributions to the field of biomedical technology through his patents and collaborations highlight his role as a leading inventor. His work in antibody library construction and chimeric antigen receptors is set to make a significant impact on future medical therapies.